Drug: Trastuzumab Injury: Aspartate aminotransferase increased Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 93044453 | Trastuzumab | Aspartate aminotransferase increased | ROCHE | 0.00 | 0 | 20160829 | JP | |
| 109648479 | Trastuzumab | Aspartate aminotransferase increased | ROCHE | 57.00 YR | F | 77 KG | 20160920 | DE |
| 121697125 | Trastuzumab | Aspartate aminotransferase increased | ROCHE | 75.91 YR | F | 92 KG | 20160725 | KR |
| 125522252 | TRASTUZUMAB | Aspartate aminotransferase increased | NOVARTIS | 44.74 YR | F | 0 | 20160805 | IE |
| 125664491 | TRASTUZUMAB | Aspartate aminotransferase increased | NOVARTIS | 39.99 YR | F | 56 KG | 20160718 | CN |
| 127435721 | TRASTUZUMAB | Aspartate aminotransferase increased | AVENTIS | 36.00 YR | F | 52 KG | 20160914 | KR |
| 1058093513 | Trastuzumab | Aspartate aminotransferase increased | ROCHE | 71.00 YR | F | 0 | 20160727 | MX |
Total Records: 7 Number of Pages: 1